Takeda Pharmaceutical Company Quiz! Trivia

Christophe Weber is the current president/CEO of Takeda Pharmaceutical. This can be inferred from the given options as his name is listed as one of the choices.

The company is focused on all of the given options: Neurology, Metabolic Disorders, and Inflammation. This means that the company's main areas of interest and specialization include these three fields. They likely conduct research, develop products, and provide services related to neurology, metabolic disorders, and inflammation.

The company's headquarters is located in Japan.

Takeda is known to be the largest pharmaceutical company in Japan.

The company was founded in 1781.

Takeda acquired Ariad pharmaceutical for $5.2 billion.

The given answer suggests that the position of the pharmaceutical company in question is among the top 15 in the world. This implies that there are 14 other pharmaceutical companies that are ranked higher in terms of various factors such as revenue, market share, or overall industry influence. It indicates that the company is considered to be one of the leading players in the global pharmaceutical industry, but not among the very top-ranked companies.

The company has gained over 30,000 employees worldwide. This indicates that the company has experienced significant growth and expansion, resulting in a large workforce. The high number of employees suggests that the company is successful and has a global presence.

In April 2015, Takeda, a pharmaceutical company, agreed to pay a settlement of $2.3 billion. The question is asking how many people this settlement was intended for. The correct answer is 9000, indicating that the settlement was meant to compensate 9000 individuals.

The revenue during the 2012 fiscal year was 16.2 billion USD.